Pain Therapeutics reported $-21045000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US USD 2.5B 703M
Acelrx Pharmaceuticals ACRX:US USD -6208000 2M
Amgen AMGN:US USD 3.5B 62M
Biogen BIIB:US USD 992.8M 82.9M
Cara Therapeutics CARA:US USD -23783000 19.37M
Eisai 4523:JP JPY 7.71B 9.53B
Eli Lilly And LLY:US USD 2.31B 308.9M
Johnson & Johnson JNJ:US USD 7.81B 876M
Novartis NOVN:VX USD 4.69B 34M
Pain Therapeutics PTIE:US USD -21045000 1.43M
Pfizer PFE:US USD 10.52B 2.78B